Novel Naphthalimide-based photosensitive theranostic agent for subcellular imaging and photodynamic

来源 :2015年全国药物化学学术会议暨第五届中英药物化学学术会议 | 被引量 : 0次 | 上传用户:ivsou
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Photodynamic therapy(PDT)that utilized singlet oxygen,generated by light irradiation,to induce cell apoptosis was an novel manner for disease treatment[1-2],in which the building of new structural photosensitizes and mechanism research in intracellular condition were two attractive fields.
其他文献
Phthalazine showed a series of biological activities,such as reduce blood press,antimicrobial,anticancer,antiinflammatory and antiepileptic[1].
Studying on the medicinal value and the SAR of natural compounds and their derivatives is one of the most important methods in the research and development of new drugs[1].
The status of histone lysine methylation regulates the gene expression.Lysine-sepcific demethylase(KDM),as one group of the histone modification regulators,has been characterized two distinct families
School of Pharmaceutical Sciences,Zhengzhou University,Zhengzhou,450001 Piperlongumine(PL,Figure 1),a natural occurring compound,has been found to be a selective antitumor agent which can increase the
Objective To investigate the neuroprotective effects and mechanisms of Shen Nao Fu Yuan Decoction and hUC-MSCs.Methods rats were randomly divided into sham operation group,model group,TCM group,stem c
Polo 样蛋白激酶(Polp-like kinase,PLKs)是一类进化上高度保守的丝/苏氨酸激酶,在DNA 复制、有丝分裂以及应激反应等多种生命活动发挥重要调控作用。
目的 探讨将紫杉醇与化合物JO 联合用药,降低紫杉醇的剂量,以期达到既降低药物的使用剂量,又减少药物的毒副作用的目的,为新药研发及临床应用提供新的思路和依据。
Human dihydroorotate dehydrogenase(hsDHODH),a flavin-dependent mitochondrial enzyme,plays a rate-limiting role in pyrimidine de novo biosynthesis,which has been identified as a potential target for th
青蒿琥酯(Artesunate 1)是中国首次得到国际承认的独立创制的新药。它是目前世界上最有效的用于治疗脑型疟疾和抗氯喹恶性疟疾的药物。它具有高效、低毒、使用方便、与氯喹无交叉抗药性等特点,经国内外大量临床实验证明,用于治疗各种危重疟疾患者和抢救脑型疟疾病人有很好的疗效。
为发现新型抗肿瘤绕丹宁不饱和酮衍生物[1-5],以氟喹诺酮酰胺骨架作为载体,设计合成了培氟沙星(绕丹宁 α,β-不饱和酮)酰胺类目标化合物 1~10(Fig.1),其结构经元素分析、1H-NMR、MS 确证.采用 MTT 法评价了目标化合物对人肝癌 Hep-3B 细胞、人 Panc-1 胰腺癌细胞及人 HL60 白血病细胞的体外增值抑制活性.